ImmunityBio Files 8-K: Other Events & Financials
Ticker: IBRX · Form: 8-K · Filed: Aug 8, 2025 · CIK: 1326110
| Field | Detail |
|---|---|
| Company | Immunitybio, Inc. (IBRX) |
| Form Type | 8-K |
| Filed Date | Aug 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
ImmunityBio dropped an 8-K on Aug 8, 2025, with other events and financials. Check it out.
AI Summary
ImmunityBio, Inc. filed an 8-K on August 8, 2025, reporting other events and financial statements. The company, formerly known as NantKwest, Inc., Conkwest, Inc., and ZelleRx Corp, is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing provides updates on significant company events and financial disclosures, which are crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing reporting on other events and financial statements, not indicating any immediate significant risks.
Key Players & Entities
- ImmunityBio, Inc. (company) — Registrant
- August 8, 2025 (date) — Date of earliest event reported
- NantKwest, Inc. (company) — Former company name
- Conkwest, Inc. (company) — Former company name
- ZelleRx Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Address of principal executive offices
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The filing indicates 'Other Events' are being reported, but the specific details of these events are not provided in the provided text excerpt.
When was ImmunityBio, Inc. previously known as NantKwest, Inc.?
The filing states the date of the name change from NantKwest, Inc. to ImmunityBio, Inc. was July 13, 2015.
What is the IRS Employer Identification Number (EIN) for ImmunityBio, Inc.?
The IRS Employer Identification Number (EIN) for ImmunityBio, Inc. is 43-1979754.
What is the SIC code for ImmunityBio, Inc.?
The Standard Industrial Classification (SIC) code for ImmunityBio, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the principal executive office address for ImmunityBio, Inc.?
The principal executive offices of ImmunityBio, Inc. are located at 3530 John Hopkins Court, San Diego, California 92121.
Filing Stats: 637 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2025-08-08 16:30:53
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share IBRX The Nasdaq Global Se
Filing Documents
- d29656d8k.htm (8-K) — 27KB
- d29656dex991.htm (EX-99.1) — 60KB
- d29656dex992.htm (EX-99.2) — 342KB
- 0001193125-25-177024.txt ( ) — 627KB
- ibrx-20250808.xsd (EX-101.SCH) — 3KB
- ibrx-20250808_lab.xml (EX-101.LAB) — 17KB
- ibrx-20250808_pre.xml (EX-101.PRE) — 11KB
- d29656d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description of Exhibit 99.1* Notice of Proposed Derivative Settlement. 99.2* Stipulation and Settlement Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Filed herewith.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMMUNITYBIO, INC. Registrant Date: August 8, 2025 By: /s/ Jason R. Liljestrom Jason R. Liljestrom General Counsel and Corporate Secretary